← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2009Last known activity
Jan 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT04938323CollaboratorPhase 2/Phase 3Jan 31, 2022
- NCT01047592Overall official - principal investigatorPhase 2Mar 1, 2009
- NCT01047592Lead sponsorPhase 2Mar 1, 2009
- NCT01047592Reponsible party - principal investigatorPhase 2Mar 1, 2009
Details
- Last known activity
- Jan 31, 2022